Open access peer-reviewed chapter

Algal Nanoparticles: Synthesis and Biotechnological Potentials

Written By

Felix LewisOscar, Sasikumar Vismaya, Manivel Arunkumar, Nooruddin Thajuddin, Dharumadurai Dhanasekaran and Chari Nithya

Submitted: 10 February 2016 Reviewed: 07 March 2016 Published: 29 June 2016

DOI: 10.5772/62909

From the Edited Volume

Algae - Organisms for Imminent Biotechnology

Edited by Nooruddin Thajuddin and Dharumadurai Dhanasekaran

Chapter metrics overview

6,654 Chapter Downloads

View Full Metrics


A nanoparticle can be defined as a small object that behaves as a whole unit in terms of its transport and properties. Nanoparticles are sized between 1 and 100 nm in diameter. Nanoparticles can act against the microbes in multiple ways, and the microbes are less likely to develop resistance against nanoparticles because it requires multiple gene mutations. The large surface-to-volume ratio of nanoparticles, their ability to easily interact with other particles, and several other features make them attractive tools in various fields. Nanoparticles are widely used various fields such as electronics, cosmetics, biomedical, and biotechnology. Nanoparticles can be synthesized by physical methods such as attrition, pyrolysis, and using some wet chemical methods. The physical and chemical methods have various drawbacks such as high cost of production, require high energy input and generation of toxic by-products. To overcome this, several biological methods are employed in the synthesis of nanoparticles. The biological methods are generally cost effective, nontoxic, and ecofriendly. This chapter focuses on the methods involved in algal-synthesized nanoparticles and its applications.


  • Nanoparticles
  • Green synthesis
  • Antibiotic activity
  • Antitumor
  • Antibiofilm

1. Introduction

Nanotechnology is a vibrant and developing area of science, engineering, and technology accomplished at the nanoscale level. The products of nanotechnology are nanoparticles or nanomaterials (NPs), lying in the range of 10−9 m and having dimensions of 1–100 nm. NPs are categorized into three types: natural nanoparticles, incidental nanoparticles, and engineered nanoparticles [1]. The large surface-to-volume ratio of nanoparticles, their ability of easy interaction with other particles, and several other features make them as an attractive tool in various fields. NPs are widely used in electronic, cosmetic, biomedical, and biotechnological applications. The efficient crystallographic and physiochemical properties of NPs make nanotechnology as an excellent area to focus. The synthesis of NPs can be achieved by some physical methods and chemical methods. The traditional and commonly used method for nanoparticles synthesis is wet method. In chemical synthesis, nanoparticles are grown in a liquid medium containing various reactants particularly reducing agents such as sodium borohydride [2], potassium bitartartarate [3], methoxypolyethylene glycol [4], or hydrazine [5]. Some stabilizing agents such as sodium dodecyl benzyl sulfate [5] or polyvinyl pyrrolidone [3] are added to the reaction mixture to prevent the agglomeration of metallic nanoparticles. Most commonly used chemical methods are chemical reduction [6], electrochemical techniques [7], and photochemical reactions in reverse micelles [8]. Commonly used physical methods are attrition and pyrolysis. Attrition involves grinding of the particles by a size-reducing mechanism. The particles are then air-classified, and oxidized nanoparticles are recovered. Pyrolysis involves burning of the precursor by passing them through an orifice at high pressure. The ash obtained is air classified to recover the oxidized nanoparticles [9]. Chemical methods are of low cost for high volume, and their major drawbacks include contamination from precursor chemicals, use of toxic solvents, and generation of hazardous by products, and the demerits of physical methods are low production rate, high cost of production, and high energy consumption [5]. There is need for replacing the toxic ingredients with environmentally safe method for synthesizing NPs. To overcome this, researchers are focusing on employing biological method for the synthesis of nanoparticles. They are generally cost effective, nontoxic, and ecofriendly [10]. So far, several plant extract [11], bacteria [12], fungi [13], enzymes [14], and algae [15] have been used for the synthesis of NPs. To our surprise, an emerging trend of synthesizing NPs using algae is developing in the recent years.

Algae are economically and ecologically important group of photosynthetic organism. They are unicellular or multicellular organisms dwelling in different environment such as freshwater, marine water, or surface of moist rocks [1618]. Algae are categorized as microalgae (microscopic) and macroalgae (macroscopic). They play a key role in medical, pharmaceutical, agriculture, aquaculture, cosmetics applications. Algae are valuable source for various commercial products such as natural dyes and biofuels [1922]. Till now, for the biosynthesis of metallic NPs, different group of algae such as Chlorophyceae, Phaeophyceae, Cyanophyceae, Rhodophyceae, and others (diatoms and euglenoids) have been used [23]. The ability of algae to accumulate metals and reduce metal ions makes them the superior contender for the biosynthesis of nanoparticles. Furthermore, algae are relatively convenient and easy to handle, along with several other advantages such as synthesis at low temperature with greater energy efficiency, less toxicity, and risk to the environment. In physical and chemical method, different commercially available surfactants were used as templates and capping agents in NPs synthesis with different morphologies. Removal of the residual components becomes a major issue. Considering this utilization of naturally eco-friendly methods having been developed which involves the synthesis of NP using different biological sources which could naturally modify the shape or size of a crystal with superior quality [24].

Among the biological materials, algae are called as ―bionanofactories‖ because both the live and dead dried biomasses were used for the synthesis of metallic nanoparticles [25]. Several algae such as Lyngbya majuscule, Spirulina platensis, and Chlorella vulgaris were used as a cost effective method for silver nanoparticles synthesis [26, 27]. The synthesis of silver nanoparticles using Ulva fasciata extract as a reducing agent and this nanoparticles inhibited the growth of Xanthomonas campestris pv. malvacearum [28]. In addition to seaweeds, microalgae such as diatoms (Navicula atomus and Diadesmis gallica) have the ability to synthesize gold nanoparticles, gold, and silica–gold bionanocomposites [29]. Comparing with other organism such as fungi, yeast, and bacteria, algae is equally an important organism in the synthesis of NPs; therefore, the study of algae-mediated biosynthesis of nanometals can be taken towards a newer branch and it has been termed as phyconanotechnology [10, 23, 30]. Thus, this work explains the potential and beneficial application of algal-mediated synthesized nanoparticles for present and future perspectives.


2. Types of nanoparticles

Figure 1.

Different types of nanoparticles.

There are two different types of NPs, inorganic NPs and organic NPs. The inorganic NPs include metal and metal oxides, which are potent antibacterial agents [31] (Figure 1). Metal oxide nanoparticles such as silver (Ag), iron oxide (Fe3O4), titanium oxide (TiO2), copper oxide (CuO), and zinc oxide (ZnO) are certain examples of inorganic NPs. Organic NPs includes poly-ɛ-lysine, quaternary ammonium compounds, cationic quaternary polyelectrolytes, N-halamine compounds, and chitosan . Organic nanoparticles are generally less stable at high temperatures. Due this reason, inorganic nanoparticles are more preferred as antimicrobial polymers [32].

2.1. Inorganic nanoparticles

So far, there are different types of inorganic metals and metal oxide NPs, which have been studied. Some important examples are detailed (Figure 2)

Figure 2.

Types of inorganic nanoparticles.

2.1.1. Silver

Silver nanoparticle (AgNP) is the most widely used antimicrobial agent against many bacteria, fungi, and viruses [33]. The antimicrobial activity AgNP was found to be size dependent, and larger particles are less active than smaller one against many pathogens in both in vitro and in vivo analysis [3436]. The resistance of bacteria towards antibiotics has made AgNPs more effective than antibiotics [37, 38]. Though there is plenty of research in AgNPs, the actual mode of action of AgNPs is still unclear [39]. In E. coli, the AgNPs create holes in the cell wall and increase the membrane permeability, thereby inactivating the cell activity [40, 41]. Some reports revealed that the Ag ions disrupt the protein structure by binding to thiol and amino groups [42]. AgNPs are photocatalytic [43], and they can generate reactive oxygenic species (ROS) [44, 45]. AgNPs are effective against both Gram-positive and Gram-negative bacteria [46, 47].

2.1.2. Titanium oxide

Titanium oxide (TiO2) is found to be effective against both Gram-positive/Gram-negative bacteria, viral, and parasitic infections [48, 49]. They are photocatalytic; their toxicity can be induced by visible light, or UV light, generates ROS [50]. TiO2 is an effective bactericidal agent and a potent sporicidal agent against wide range of bacteria [51].

2.1.3. Zinc oxide

ZnO nanoparticles (ZnONPs) are another broad spectrum antibacterial agent, based on concentration and size of the NPs, and they are effective against methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant S. aureus (MRSA), and methicillin-resistant Streptococcus epidermis (MSSE) [52]. They are of low cost and found to inhibit the growth of a wide range of pathogenic bacteria (Klebsiella pneumoniae, Listeria monocytogenes, Salmonella enteritidis) [53], S. mutants, Lactobacillus sp., and E. coli [53, 54], with less toxicity to human cells. Their UV blocking and anti-biofilm activity makes them as a suitable coating material for medical and other devices, and it is approved by the Food and Drug Administration (FDA) in the treatment of disease and ingredients in food additives [50, 55].

2.1.4. Iron oxide

Iron oxide is generally inactive in their bulk form. Reducing their size to nanoscale makes them a potential antimicrobial agent. Iron oxide nanoparticles-coated surfaces prevent the adhesion and colonization of Gram-positive and Gram-negative bacteria [56].

2.1.5. Gold

As compared to Ag, Au nanoparticles are less effective and lack antimicrobial properties when used alone but found to be effective when used in combination with antibiotics such as ampicillin [57, 58], vancomycin [59], and lysozyme (an antibacterial enzyme) [60]. The Au nanoparticles can also be used in combination with nonantibiotic molecules such as amino substituted pyrimidines [61] and citrate, which induces the generation of ROS and mutations, hence used in cancer therapy [62].

2.1.6. Copper oxide

Despite copper oxide (CuO) nanoparticles are used as antibacterial agents, they are less effective than that of Ag and ZnO. So a comparatively higher concentration is required to get desired results. But some bacteria are more susceptible to CuO than Ag. For example, E. coli and S. aureus were more sensitive to silver but B. subtilis and B. anthracis were more sensitive to Cu [63, 64]. The cell wall composition of B. subtilis and B. anthracis is rich in amine and carboxyl groups, which allow the strong affinity of CuO towards the bacteria [65, 66]. CuO NPs exhibit antibacterial activity by membrane disruption and ROS production [65].

2.1.7. Magnesium oxide

Magnesium oxide (MgO) nanoparticles are efficient antimicrobial agent exhibiting bactericidal activity against both Gram-positive and Gram-negative bacteria, spores and viruses. The MgO NPs can be prepared from available and economical precursors. Along with membrane disruption and ROS generation, it also inhibits the essential enzymes of bacteria [50, 67].

2.1.8. Nitric oxide

Nitric oxide (NO) nanoparticles are highly reactive antibacterial agent. Similar to other nanoparticles, the activity of NO is also size dependent [68, 69]. The mode of inhibition is by the production of reactive nitrogen species (RNS) rather than ROS. They are effective against MRSA and various biofilm forming bacterial species [70, 71].

2.1.9. Aluminium oxide

Aluminium oxide is a mild antibacterial agent effective only at higher concentrations [65]. There mode of inhibition is by pit formation, perforation, and membrane disruption leading to cell death [66].

2.2. Organic nanoparticles

Some of the well-known examples of organic NPs are discussed below (Figure 3).

Figure 3.

Types of organic nanoparticles.

2.2.1. Poly-ɛ-lysine

Poly-ɛ-lysine, a cationic homopeptide of L-lysine is effective against Gram-positive bacteria and spores of B. coagulans, B. subtilis, and B. stearothermophilus [72].

2.2.2. Quaternary ammonium compounds

Quaternary ammonium compounds are well known disinfectants and their antimicrobial property dependents on the chain length. The positively charged moieties of the compounds are attached to the negatively charged bacterial membrane by weak electrostatic interaction, followed by the insertion of hydrophobic tail of the compound in to the bacterial hydrophobic membrane core leading to the denaturation of structural proteins and enzymes [73].

2.2.3. Cationic quaternary polyelectrolytes

They are synthesized from methacrylic monomers such as 2-(dimethylamino) ethyl methacrylate and majority of them are derivatives of acrylic and methacrylic compounds. These molecules possess a wide range of biological applications due to their structural flexibility through the alteration of hydrophobicity, molecular weight, surface charge and other factors [74].

2.2.4. N-halamine compounds

N-halamine compounds are formed by the halogenation of imide amide or amine groups with one or more nitrogen–halogen covalent bonds. These are high stable compounds releasing free active halogen groups slowly in to the environment leading to the inhibition or inactivation of the microbial cells [75].

2.2.5. Chitosan

Chitosan NPs are biocompatible, nontoxic, and have the ability to act as absorption enhancer. These characteristics make the chitosan nanoparticles as an effective antimicrobial agent with broad spectrum activity against a wide range of bacteria, fungi and viruses. The antibacterial activity of chitosan nanoparticles depends on several factors such as pH and the nature of solvent [76, 77]. The use of chitosan along with metal nanoparticles is not feasible since chitosan reduced the activity of metal nanoparticles such as Zn. It can be used in combination with antibiotics [76, 78]. Even though some studies state that the interaction of cells with chitosan lead to membrane destabilization, followed by lysis and cell death, the detailed mode of action is unclear [79].

2.3. Synthesis of NPs using algae

The abundance and ease of availability of algae make them good and worthwhile sources for the synthesis of metallic nanoparticles [80]. Synthesis of nanoparticles using algae can be performed in three important steps, (i) preparation of algal extract in water or in an organic solvent by heating or boiling it for a certain duration, (ii) preparation of molar solutions of ionic metallic compounds and (iii) incubation of algal solutions and molar solutions of ionic metallic compounds followed either by continuous stirring or without stirring for a certain duration under controlled conditions [10, 30]. The synthesis of NPs is dose dependent and it is also related to the type of algae used. There are a variety of biomolecules responsible for the reduction of metals which include polysaccharides, peptides, and pigments. Stabilizing and capping the metal nanoparticles in aqueous solutions is done by proteins through amino groups or cysteine residues and sulfated polysaccharides [81]. Synthesis of nanoparticles using algae takes comparatively shorter time period than the other biosynthesizing methods [10, 30]. So far, several seaweeds (Sargassum wightii and Fucus vesiculosus) have been used for the synthesizing AgNPs of different sizes and shapes [81, 82]. Marine algae are meagerly explored for the synthesis of NPs. C. vulgaris has strong binding ability towards tetrachloroaurate ions to form algal-bound gold reducing into Au(O). Approximately 88% of algal-bound gold attained metallic state, and the crystals of gold were accumulated in the inner and outer parts of cell surfaces with tetrahedral, decahedral, and icosahedral structures [83]. S. platensis has been for the extracellular synthesis of gold, silver, and Au/Ag bimetallic NPs [26]. Senapati et al. [84] reported the intracellular production of gold nanoparticles using Tetraselmis kochinensis. The biomass of the brown alga F. vesiculosus was reported for the reduction of Au(III)–Au(O) [82]. In addition to seaweeds, microalgae such as diatoms (N. atomus and D. gallica) have the ability to synthesize gold nanoparticles, gold, and silica–gold bionanocomposites [15].

2.4. Application of algal-synthesized NPs

The biomedical application of algal-synthesized NPs is significantly becoming more important due to their antibacterial, antifungal, anti-cancer, and wound healing activity. They are given (Figure 4).

Figure 4.

Applications of algal-synthesized nanoparticles.

2.4.1. Antibacterial activity

Algal-synthesized NPs are known to possess efficient antibacterial activity (Figure 5; Table 1). Brown alga (Bifurcaria bifurcate) is reported for the synthesis of copper oxide nanoparticle (5–45 nm) exhibiting antibacterial activity against Enterobacter aerogenes (Gram-negative) and S. aureus (Gram-positive) [85]. Gold nanoparticles synthesized using Galaxaura elongata (powder or extract) were evaluated for their antibacterial activities which showed better antibacterial effects against E. coli, K. pneumoniae, MRSA, S. aureus, and Pseudomonas aeruginosa [86]. In another work, silver chloride (AgCl) NPs synthesized using marine alga Sargassum plagiophyllum were analyzed using fluorescence and electron microscopy showed bactericidal activity against E. coli [87]. Synthesis of AgNPs using fresh extract and whole cell of microalga Chlorococcum humicola inhibited the growth of Gram-negative bacteria E. coli (ATCC 1105) [88]. In a recent report, the aqueous extract of a diatom Amphora-46 was used for the light-induced biosynthesis of polycrystalline AgNPs, in which fucoxanthin a photosynthetic pigment was responsible for the reduction of Ag ion. Furthermore, the synthesized AgNPs were tested against Gram-positive and Gram-negative bacteria for its antibacterial activity [89].

Figure 5.

Different nanoparticles and their mode of inhibition against bacteria.

AgNPs synthesized using Caulerpa racemose, a marine algae, exhibited antibacterial activity against human pathogens such as S. aureus and Proteus mirabilis [90]. The cellular metabolites of Microcoleus sp. used to synthesize AgNPs, and it enhanced the antibacterial activity of antibiotics against Proteus vulgaris, Salmonella typhi, Vibrio cholera, Streptococcus sp., Bacillus subtilis, S. aureus, and E. coli [91]. In a work done by Merin et al. [92], he used marine microalgae C. calcitrans, C. salina, I. galbana, and T. gracilis were used for the synthesis of AgNPs and tested the antibacterial activity of AgNPs against E. coli, Klebsiella sp., Proteus sp., and Pseudomonas sp. were tested high inhibitions over the growth of E. aerogenes, S. typhi, and P. vulgaris was exhibited by AgNPs synthesized using seaweed extracts of Sargassum cinereum [93]. In addition to antibacterial activity, the nanoparticles synthesized by seaweed extracts do have stabilizing effect on cotton fabrics [94].

Algae NPs Size Shape Intracellular (IC) or extracellular (EC) Pathogens References
Bifurcaria bifurcate CuO 5–45 nm Spherical and elongated IC E. aerogenes
S. aureus
Galaxaura elongata Au 3.85–77.13 nm  Spherical IC E. coli
K. pneumoniae
S. aureus
P. aeruginosa
Sargassum plagiophyllum AgCl  18–42 nm Spherical IC E. coli [87]
Chlorococcum humicola Ag 4 and 6 nm Spherical IC E. coli (ATCC 1105) [88]
Amphora-46 Ag 5–70 nm Spherical IC [89]
Caulerpa racemose Ag 5–25 nm Spherical and triangle S. aureus and P. mirabilis [90]
Microcoleus sp. Ag P. vulgaris, S. typhi, V. cholera, Streptococcus sp., B. subtilis, S. aureus, E. coli [91]
Ulva fasciata Ag 28–41 nm Spherical IC Xanthomonas campestris pv. malvacearum [96]
Turbinaria conoides Au 60 nm Triangle, rectangle & square IC Streptococcus sp., B. subtilis and
K. pneumoniae
Padina pavonica Ag 10–72 nm Spherical IC Fusarium oxysporum f. sp. vas infectum
Xanthomonas campestris pv. malvacearum
Gracilaria dura Ag 6 nm Spherical IC B. pumilus (accession number HQ318731) [100]
Spirulina platensis Au 5 nm IC B. subtilis and S. aureus [101]

Table 1.

Different types of algal-synthesized NPs and its antibacterial activity.

The aqueous extract of red marine algae Gracilaria corticata as the reducing agent was explored for its antibacterial activity against Gram-positive and Gram-negative bacteria [95]. U. fasciata-based AgNPs were synthesized and used to inhibit the growth of Xanthomonas campestris pv. malvacearum [96]. Another work shows the antibacterial activity of AuNPs synthesized using marine brown algae Turbinaria conoides, against Streptococcus sp., B. subtilis, and K. pneumoniae [97]. Ag, Au, and bimetallic alloy Ag–Au nanoparticles were synthesized from marine red alga, Gracilaria sp., exhibited good antibacterial activity against Gram-positive bacteria S. aureus and Gram-negative bacteria K. pneumoniae [98]. Extracellular synthesis of AgNPs from the thallus broth of marine algae Padina pavonica (Linn.) inhibited the growth of cotton Fusarium wilts (Fusarium oxysporum f. sp. vasinfectum) and bacterial leaf blight (Xanthomonas campestris pv. malvacearum) [99]. Bactericidal activity of AgNPs and nanocomposite material synthesized using agar extracted from the red alga Gracilaria dura was tested against B. pumilus (accession number HQ318731) [100]. In a work done by Suganya et al. [101] blue green alga S. platensis protein mediated synthesis of AuNPs was performed; further, it showed efficient antibacterial activity against Gram-positive bacteria (B. subtilis and S. aureus) (Table 2)

Nanoparticle Target organism References
Silver nanoparticles S. paratyphi, P. aeruginosa, S. epidermidis [112, 113]
Bismuth oxide aqueous colloidal nanoparticles C. albicans, S. mutans [114, 115]
Nano-oil formulation from Mentha piperita L Staphylococcus sp. [116]
Nano-emulsion (detergent, oil, and water) in combination with cetylpyridinium chloride A. baumannii [117]
Silver- and gold-incorporated polyurethane, polycaprolactam, polycarbonate, and polymethylmethacrylate E. coli [118]
Silver nanoparticles in combination with nystatin and chlorhexidine C. albicans, C. glabrata [119]
Silver nanoparticle and 12-methacryloyloxydodecylpyridinium bromide (MDPB) Dental plaque microcosm biofilms [120, 121]
Copper P. aeruginosa [108]
Zinc Actinobacillus pleuropneumoniae, S. Typhimurium, Haemophilus parasuis, E. coli, S. aureus, S. suis [122]
Magnetite nanoparticles C. albicans [56]
Eugenia carryophyllata essential oil stabilized by iron
oxide/oleic acid core/shell nanostructures
S. aureus [123, 124]
Zinc and copper oxide nanoparticles S. mutans [125]
Zerovalent bismuth nanoparticle S. mutans [114]
Dextran sulfate nanoparticle complex containing ofloxacin and levofloxacin P. aeruginosa [126]
PEG-stabilized lipid nanoparticles loaded with terpinen-4-ol C. albicans [127]
Magnesium fluoride nanoparticles S. aureus, E. coli [128130]
Yttrium fluoride nanoparticles S. aureus, E. coli [131]
Iron oxide/oleic acid in combination with essential oil from Rosmarinus officinalis C. albicans, C. tropicalis [132]
Gold nanoparticles and methylene blue C. albicans [133]
Starch-stabilized silver nanoparticles S. aureus, P. aeruginosa [134]
Iron oxide–oleic acid nanofluid S. aureus [124]
Quaternary ammonium polyethylenimine nanoparticles Oral biofilms [41]
Zinc oxide nanoparticles, chitosan nanoparticles, and combination of both E. faecalis [135]
Polyurethane nanocomposite S. epidermidis [136]

Table 2.

Antibiofilm activity of different NPs against microbial pathogen.

2.4.2. Antifungal activity

Algal-synthesized NPs were used as efficient antifungal agents. Only countable number of work has been carried out in this aspect. This includes the synthesis AgNPs using the aqueous extract of red seaweed Gelidiella acerosa as the reducing agent exhibited antifungal property against Humicola insolens (MTCC 4520), Fusarium dimerum (MTCC 6583), Mucor indicus (MTCC 3318), and Trichoderma reesei (MTCC 3929) [102]. In another report, the effect of the algal (Sargassum longifolium)-mediated AgNPs against the pathogenic fungi Aspergillus fumigatus, Candida albicans, and Fusarium sp. was determined [103].

2.4.3. Anticancer activity

In a work done by Boca et al. [104] synthesized chitosan-coated silver nano-triangles (Chit-AgNPs) were used as a photothermal agents against a line of human nonsmall lung cancer cells (NCI-H460) [104]. In another work, AgNPs (10 nm) were synthesized using Sargassum vulgare and its ability to kill cancerous human myeloblastic leukemic cells HL60 and cervical cancer cells HeLa was tested [105].

2.4.4. Other applications

Algal-synthesized NPs are explored in certain other area of applications, which include the synthesis of spherical palladium nanocrystals via aqueous Na2 [PdCl4] solution using the photosynthetic reaction within C. vulgaris, which can be used as a material for recycling as a catalyst for the Mizoroki–Heck cross-coupling reaction [106]. The antioxidant potentials of AgNPs synthesized using G. corticata was also determined [95]. In another work, AuNPs were synthesized using the dried biomass of an edible freshwater epilithic red alga, Lemanea fluviatilis (L.) C. Ag., as both reductant and stabilizer; further, its antioxidant property was determined using DPPH assay [107].

2.5. Future application of algal-synthesized NPs

2.5.1. Antibiofilm agents

The use of nanoparticles as antibiofilm agents is an emerging area of research. Due to the extensive use and misuse of antibiotics, many of the pathogens acquired resistance toward multiple drugs. As the bacteria are less likely to develop resistance against nanoparticles, they can be used as a promising therapeutic agent against biofilms. Nanoparticles have the ability to penetrate EPS and the cell membranes (Figure 6). Silver nanoparticles were found to be more prevalent than the other ones, and they exhibit antibiofilm activity against both Gram-positive and Gram-negative pathogens. In a work done by LewisOscar et al. [108]. Chemical synthesis of CuNPs was performed by one-pot synthesized method and used for biofilm inhibition against P. aeruginosa PA14, P. aeruginosa ATCC10145 and some clinical isolated of P. aeruginosa. Along with the biofilm, CuNPs also weakened the extracellular polymeric substance and cell surface hydrophobicity of P. aeruginosa.

Figure 6.

Antibiofilm activity of different nanoparticles.

The zero-valent selenium and tellurium NPs synthesized using Stenotrophomonas maltophilia and Ochrobacterium sp. were found to be effective against biofilms of E. coli, P. aeruginosa, and S. aureus [109]. Similarly, AgNP synthesized from E. faecalis, when used in the form of nanocolloids, inhibited the biofilm of multidrug resistant pathogens [110]. Green-synthesized AgNP coated on medical devices inhibited the S. aureus biofilms [111]. Some other potential NPs against biofilm of different Gram-negative and Gram-positive bacteria are given below in Table 2.

2.5.2. Nanocomposite

The diatom Stauroneis sp. was used for the preparation of silicon–germanium nanocomposite, and this method of nanocomposite preparation has great importance for possible future applications due to its accessibility, simplicity, and effectiveness [137].

2.5.3. Lipid nanoparticles

There are possibilities for the production of lipid nanoparticles with the help of lipid-rich marine organisms such as algae, fungi, and bacteria [138]. Lipid nanoparticles can be synthesized from the organisms through heating to liquefy fatty acids; incorporating active agents of pharmacological and cosmetics importance; adding a hot surfactant; and stirring or homogenized under high pressure by ultrasound. These can be used in the production of food stuffs, cosmetics, and medicines [139].

2.5.4. Biosensing

Algal-synthesized NPs can be explored in biosensing applications. Such as, AuNPs has been proved as an important tool for hormone (HCG) detection in pregnant women urine sample [140]. Platinum (Pt) NPs act as a novel biosensor with high sensitivity for the determination of adrenaline for the treatment of allergies, heart attack, asthma, and cardiac surgery [141]. Synthesis of nanoscale Au–Ag alloy prepared using chloroplasts exhibited high electrocatalytic activity for 2-butanone at room temperature which can be developed as a tool for detecting cancer at early stages [142].

2.6. Conclusion

The developing era of nanoscience is a renowned gift for the development of science all over the world. Despite numerous studies conducted over the last decade, there are still considerable gaps in our knowledge about the biotechnological potential of green-synthesized nanoparticles. Furthermore, the precise basis of their antibiotic and antibiofilm activity has yet to be defined. However, the toxicity of nanoparticles to eukaryotic cells is a legitimate concern and still remains uncharacterized. One way of avoiding this potential drawback might be to target green-synthesized nanoparticles to the specific site of an infection so that toxic nanoparticles concentrations are localized. In addition, improvements in the way that green-synthesized nanoparticles are incorporated into medical devices could increase their efficacy and diminish any side effects, but considerable research effort is still required to perfect this technology.



Financial support provided to Dr. C.N by the DST INSPIRE faculty scheme is gratefully acknowledged (DST/Inspire Faculty Award/2012 [IFA12- LSPA13]). The authors gratefully acknowledge DBT [BT/PR7005/PBD26/357/2012 dated: 26.03.2015 and BT/PR6619/PBD/26/310/2012] for their financial assistance, and FIST program provided by the DST-FIST scheme [SR/FST/LSI-523/2012] is gratefully acknowledged.


  1. 1. Buzea C, Pacheco II, Robbie K (2007). Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2 (4): 17–71.
  2. 2. Kim JS, Kuk E, Yu KN, Kim J, Park SJ, Lee HJ (2007). Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biomed 3: 95–101.
  3. 3. Tan Y, Dai X, Li Y, Zhu D (2003). Preparation of gold, platinum, palladium and silver nanoparticles by the reduction of their salts with a weak reductant-potassium bitartrate. J Mater Chem 13: 1069–1075.
  4. 4. Mallick K, Witcomb MJ, Scurrell MS (2004). Polymer stabilized silver nanoparticles: a photochemical synthesis route. J Mater Sci 39 (14): 4459–4463.
  5. 5. Li Y, Duan X, Qian Y, Li Y, Liao H (1999). Nanocrystalline silver particles: synthesis, agglomeration, and sputtering induced by electron beam. J Colloid Interface Sci 209 (2): 347–349.
  6. 6. Balantrapu K, Goia DV (2009). Silver nanoparticles for printable electronics and biological applications. J Mater Res 24 (9): 2828–2836.
  7. 7. Rodrıguez-Sánchez L, Blanco MC, Lopez-Quintela MA (2000). Electrochemical synthesis of silver nanoparticles. J Phys Chem B 104: 9683–9688.
  8. 8. Taleb A, Petit C, Pileni MP (1997). Synthesis of highly monodisperse silver nanoparticles from AOT reverse micelles: a way to 2D and 3D self-organization. Chem Mater 9 (4): 950–959.
  9. 9. Chen S, Zhao X, Xie H, Liu J, Duan L, Ba X, Zhao J (2012). Photoluminescence of undoped and Ce-doped SnO2 thin films deposited by sol–gel-dip-coating method. Appl Surf Sci 258: 3255–3259.
  10. 10. Thakkar KN, Mhatre SS, Parikh RY (2010). Biological synthesis of metallic nanoparticles. Nanomed Nanotechnol Biomed 6: 257–262.
  11. 11. Gilaki M (2010). Biosynthesis of Silver nanoparticles using plant extracts. J Biol Sci 10 (5): 465–467.
  12. 12. Saifuddin N, Wong CW, Nur Yasumira AA (2009). Rapid biosynthesis of silver nanoparticles using culture supernatant of bacteria with microwave irradiation. J Chem 6 (1): 61–70.
  13. 13. Balaji DS, Basavaraja S, Deshpande R, Mahesh DB, Prabhakar BK, Venkataraman A (2009). Extracellular biosynthesis of functionalized silver nanoparticles by strains of Cladosporium cladosporioides fungus. Colloids Surf B 68 (1): 88–92.
  14. 14. Schneidewind H, Schüler T, Strelau KK, Weber K, Cialla D, Diegel M, Mattheis R, Berger A, Möller R, Popp J (2012). The morphology of silver nanoparticles prepared by enzyme-induced reduction. Beilstein J Nanotechnol 203: 404–414.
  15. 15. MubarakAli D, Sasikala M, Gunasekaran M, Thajuddin N (2013). Biosynthesis and characterization of silver nanoparticles using marine cyanobacterium, Oscillatoria willei NTDM01. Dig J Nanomater Biostruct 6: 385–390.
  16. 16. Thajuddin N, Subramanian G (1992). Survey of cyanobacterial flora of the southern east coast of India. Bot Mar 35: 305–314.
  17. 17. Thajuddin N, Subramanian G (2005). Cyanobacterial biodiversity and potential application in biotechnology. Curr Sci 89 (1): 47–57.
  18. 18. LewisOscar F, Bakkiyaraj D, Nithya C, Thajuddin N (2014). Deciphering the diversity of microalgal bloom in wastewater—an attempt to construct potential consortia for bioremediation. JCPAM 3 (2): 92–96.
  19. 19. Lee R (2008). Phycology. Cambridge: Cambridge University Press.
  20. 20. Johansen MN (ed) (2011). Microalgae: biotechnology, microbiology and energy. New York: Nova Science.
  21. 21. Borowitzka MA (2013). High-value products from microalgae—their development and commercialisation. J Appl Phycol 25: 743–756.
  22. 22. Fon Sing S, Isdepsky A, Borowitzka MA, Moheimani NR (2013). Production of biofuels from microalgae. Mitig Adapt Strateg Glob Chang 18: 47–720.
  23. 23. Sharma A, Sharma S, Sharma K, Chetri SPK, Vashishtha A, Singh P, Kumar R, Rathi B, Agrawal V (2015). Algae as crucial organisms in advancing nanotechnology: a systematic review. J Appl Phycol 2014: 1–16. doi:10.1007/s10811-015-0715-1.
  24. 24. Sharma D, Kanchi S, Bisetty K (2015). Biogenic synthesis of nanoparticles: a review. Arab J Chem. doi:10.1016/j.arabjc.2015.11.002.
  25. 25. Davis SA, Patel HM, Mayes EL, Mendelson NH, Franco G, Mann S (1998). Brittle bacteria: a biomimetic approach to the formation of fibrous composite materials. Chem Mater 10: 2516–2524.
  26. 26. Chakraborty N, Banerjee A, Lahiri S, Panda A, Ghosh AN, Pal R (2009). Biorecovery of gold using cyanobacteria and an eukaryotic alga with special reference to nanogold formation—a novel phenomenon. J Appl Phycol 21: 145–152.
  27. 27. Niu H, Volesky B (2000). Gold-cyanide biosorption with L-cysteine. J Chem Technol Biotechnol 75: 436–442.
  28. 28. Rajesh S, Raja DP, Rathi JM, Sahayaraj K (2012). Biosynthesis of silver nanoparticles using Ulva fasciata (Delile) ethyl acetate extract and its activity against Xanthomonas campestris pv. Malvacearum. J Biopestic 5: 119–128.
  29. 29. Schrofel A, Kratošová G, Krautová M, Dobročka E, Vávra I (2011). Biosynthesis of gold nanoparticles using diatoms—silica-gold and EPS-gold bionanocomposite formation. Nanopart Res 13: 3207–3216.
  30. 30. Rauwel P, Küünal S, Ferdov S, Rauwel E (2015). A review on the green synthesis of silver nanoparticles and their morphologies studied via TEM. Adv Mater Sci Eng 682749: 9.
  31. 31. Loomba L, Scarabelli T (2013). Metallic nanoparticles and their medicinal potential. Part II: aluminosilicates, nanobiomagnets, quantum dots and cochleates. Ther Deliv 4(9): 1179–1196.
  32. 32. Jain A, Duvvuri LS, Farah S, Beyth N, Domb AJ, Khan W (2014). Antimicrobial polymers. Adv Healthcare Mater 3: 1969–1985.
  33. 33. Rai M, Yadav A, Gade A (2009). Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27 (1): 76–83.
  34. 34. Poulose S, Panda T, Nair PP, Th´eodore T (2014). Biosynthesis of silver nanoparticles. J Nanosci Nanotechnol 14 (2): 2038–2049.
  35. 35. Panacek A, Kvítek L, Prucek R, Kolar M, Vecerova R, Pizúrova N, Sharma VK, Nevecna T, Zboril R (2006). Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B 110 (33): 16248–16253.
  36. 36. Alberti S, Böhse K, Arndt V, Schmitz A, Höhfeld J (2004). The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator. Mol Biol Cell 15 (9): 4003–4010.
  37. 37. Leid JG, Ditto AJ, Knapp A, Shah PN, Wright BD, Blust R, Christensen L, Clemons CB, Wilber JP, Young GW, Kang AG, Panzner MJ, Cannon CL, Yun YH, Youngs WJ, Seckinger NM, Cope EK (2012). In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria. J Antimicrob Chemother 67 (1): 138–148.
  38. 38. Chernousova S, Epple M (2013). Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chem Int Ed 52 (6): 1636–1653.
  39. 39. Majdalawieh A, Kanan MC, El-Kadri O, Kanan SM (2014). Recent advances in gold and silver nanoparticles: synthesis and applications. J Nanosci Nanotechnol 14 (7): 4757–4780.
  40. 40. Sondi I, Salopek-Sondi B (2004). Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram negative bacteria. J Colloid Interface Sci 275 (1): 177–182.
  41. 41. Beyth N, Yudovin-Farber I, Perez-Davidi M, Domb AJ, Weiss EI (2010). Polyethyleneimine nanoparticles incorporated into resin composite cause cell death and trigger biofilm stress in vivo. Proc Natl Acad Sci USA 107 (51): 22038–22043.
  42. 42. Choi O, Deng KK, Kim NJ, Ross L Jr., Surampalli RY, Hu Z (2008). The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res 42(12): 3066–3074.
  43. 43. Ashok Kumar D, Palanichamy V, Roopan M (2014). Photocatalytic action of AgCl nanoparticles and its antibacterial activity. J Photochem Photobiol B 138: 302–306.
  44. 44. Ninganagouda S, Rathod V, Singh D, Hiremath J, Singh AK, Mathew J, Manzoor ul-Haq (2014). Growth kinetics and mechanistic action of reactive oxygen species released by silver nanoparticles from Aspergillus niger on of reactive oxygen species. J Phys Chem B 112(43): 13608–13619.
  45. 45. Khurana C, Vala AK, Andhariya N, Pandey OP, Chudasama B (2014). Antibacterial activities of silver nanoparticles and antibiotic-adsorbed silver nanoparticles against biorecycling microbes. Environ Sci Process Impacts 16(9): 2191–2198.
  46. 46. Shahverdi R, Fakhimi A, Shahverdi HR, Minaian S (2007). Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomed Nanotechnol Biomed 3(2): 168–171.
  47. 47. Brady-Est´evez S, Kang S, Elimelech M (2008). A single-walled-carbon-nanotube filter for removal of viral and bacterial pathogens. Small 4(4): 481–484.
  48. 48. Zan L, Fa W, Peng T, Gong ZK (2007). Photocatalysis effect of nanometer TiO2 and TiO2-coated ceramic plate on Hepatitis B virus. J Photochem Photobiol B 86(2): 165–169.
  49. 49. Blecher K, Nasir A, Friedman A (2011). The growing role of nanotechnology in combating infectious disease. Virulence 2(5): 395–401.
  50. 50. Hamal B, Haggstrom JA, Marchin GL, Ikenberry MA, Hohn K, Klabunde KJ (2010). A multifunctional biocide/sporocide and photocatalyst based on titanium dioxide (TiO2) codoped with silver, carbon, and sulfur. Langmuir 26(4): 2805–2810.
  51. 51. Palanikumar L, Ramasamy SN, Balachandran C (2014). Size dependent antimicrobial response of zinc oxide nanoparticles. IET Nanobiotechnol 8(2): 111–117.
  52. 52. Jin T, Sun D, Su JY, Zhang H, Sue HJ (2009). Antimicrobial efficacy of zinc oxide quantum dots against Listeria monocytogenes, Salmonella enteritidis, and Escherichia coli O157:H7. J Food Sci 74(1): 46–52.
  53. 53. Liu Y, He L, Mustapha A, Li H, Hu ZQ, Lin M (2009). Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157:H7.‖ J Appl Microbiol 107(4): 1193–1201.
  54. 54. Espitia PJP, Nilda de Fátima Ferreira Soares, Sélia dos Reis Coimbra J, José de Andrade N, Cruz RS, Medeiros EAA (2012). Zinc oxide nanoparticles: synthesis, antimicrobial activity and food packaging applications. Food Bioprocess Technol 5: 1447–1464.
  55. 55. Anghel I, Grumezescu AM, Andronescu E, Anghel AG, Ficai A, Saviuc C, Grumezescu V, Vasile BS, Chifiriuc MC (2012). Magnetite nanoparticles for functionalized textile dressing to prevent fungal biofilms development. Nanoscale Res Lett 7(1): 501.
  56. 56. Brown AN, Smith K, Samuels TA, Lu J, Obare SO, Scott ME (2012). Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Appl Environ Microbiol 78(8): 2768–2774.
  57. 57. Chamundeeswari M, Sobhana SSL, Jacob JP et al. (2010). Preparation, characterization and evaluation of a biopolymeric gold nanocomposite with antimicrobial activity. Biotechnol Appl Biochem 55(1): 29–35.
  58. 58. Varisco M, Khanna N, Brunetto PS, Fromm KM (2014). New antimicrobial and biocompatible implant coating with synergic silver-vancomycin conjugate action. Chem Med Chem 9(6): 1221–1230.
  59. 59. Chen WY, Lin JY, Chen WJ, Luo L, Wei-Guang Diau E, Chen YC (2010). Functional gold nanoclusters as antimicrobial agents for antibiotic-resistant bacteria. Nanomedicine 5(5): 755–764.
  60. 60. Zhao Y, Tian Y, Cui Y, Liu W, Ma W, Jiang X (2010). Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria. J Am Chem Soc 132(35): 12349–12356.
  61. 61. Raji V, Kumar J, Rejiya CS, Vibin M, Shenoi VN, Abraham A (2011). Selective photothermal efficiency of citrate capped gold nanoparticles for destruction of cancer cells. Exp Cell Res 317(14): 2052–2058.
  62. 62. Pey P, Packiyaraj MS, Nigam H, Agarwal GS, Singh B, Patra MK (2014). Antimicrobial properties of CuO nanorods and multi-armed nanoparticles against B. anthracis vegetative cells and endospores. Beilstein J Nanotechnol 5: 789–800.
  63. 63. Ruparelia JP, Chatterjee AK, Duttagupta SP, Mukherji S (2008). Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater 4 (3): 707–716.
  64. 64. Pelgrift RY, Friedman AJ (2013). Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev 65 (13–14): 1803–1815.
  65. 65. Huh AJ, Kwon YJ (2011). Nanoantibiotics: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 156 (2): 128–145.
  66. 66. Imada K, Sakai S, Kajihara H, Tanaka S, Ito S (2015). Magnesium oxide nanoparticles induce systemic resistance in tomato against bacterial wilt disease. doi:10.1111/ppa.12443.
  67. 67. Slomberg DL, Lu Y, Broadnax AD, Hunter RA, Carpenter AW, Schoenfisch MH (2013). Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles. ACS Appl Mater Interfaces 5 (19): 9322–9329.
  68. 68. Kutner AJ, Friedman AJ (2013). Use of nitric oxide nanoparticulate platform for the treatment of skin and soft tissue infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol 5 (5): 502–514.
  69. 69. Han G, Martinez LR, Mihu MR, Friedman AJ, Friedman JM, Nosanchuk JD (2009). Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection. Plos One 4 (11): ID e7804.
  70. 70. Hetrick EM, Shin JH, Paul HS, Schoenfisch MH (2009). Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 30 (14): 2782–2789.
  71. 71. Hiraki J (1995). Basic and applied studies on ε-polylysine. J Antibact Antifung Agents 23: 349–354.
  72. 72. Beyth N, Houri-Haddad Y, Domb A, Khan W, Hazan R (2015). Alternative antimicrobial approach: nano-antimicrobial materials. Evid Based Complement Alternat Med ID246012: 16.
  73. 73. Munoz-Bonilla A, Fernandez-Garcia M (2012). Polymeric materials with antimicrobial activity. Prog Polym Sci 37 (7): 281–339.
  74. 74. Denyer SP, Stewart GSAB (1998). Mechanisms of action of disinfectants. Int Biodeterior Biodegrad 41 (3–4): 261–268.
  75. 75. Chung YC, Wang HL, Chen YM, Li SL (2003). Effect of abiotic factors on the antibacterial activity of chitosan against waterborne pathogens. Bioresour Technol 88 (3): 179–184.
  76. 76. Tavaria FK, Costa EM, Gens EJ, Malcata FX, Pintado ME (2013). Influence of abiotic factors on the antimicrobial activity of chitosan. J Dermatol 40 (12): 1014–1019.
  77. 77. Tin S, Sakharkar KR, Lim CS, Sakharkar MK (2009). Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa. Int J Biol Sci 5 (2): 153–160.
  78. 78. Ibrahim M, Tao Z, Hussain A et al. (2014). Deciphering the role of Burkholderia cenocepacia membrane proteins in antimicrobial properties of chitosan. Arch Microbiol 196 (1): 9–16.
  79. 79. Reddy P, Urban S (2008). Linear and cyclic C18 terpenoids from the southern Australian marine brown alga Cystophora moniliformis. J Nat Prod 71 (8): 1441–1446.
  80. 80. Kannan RRR, Stirk WA, Staden JV (2013). Synthesis of silver nanoparticles using the seaweed Codium capitatum P.C. Silva (Chlorophyceae). S Afr J Sci Bot 86: 1–4.
  81. 81. Singaravelu G, Arockiyamari J, Ganesh Kumar V, Govindaraju K (2007). A novel extracellular synthesis of monodisperse gold nanoparticles using marine alga, Sargassum wightii Greville. Colloids Surf B Biointerfaces 57: 97–101.
  82. 82. Mata YN, Torres E, Blázquez ML, Ballester A, González F, Munoz JA (2009). Gold(III) biosorption and bioreduction with the brown alga Fucus vesiculosus. J Hazard Mater 166: 612–618.
  83. 83. Jianping X, Jim YL, Daniel ICW, Yen PT (2007). Identification of active biomolecules in the high-yield synthesis of single-crystalline gold nanoplates in algal solutions. Small 3 (4): 668–672.
  84. 84. Senapati S, Syed A, Moeez S, Kumar A, Ahmad A (2012). Intracellular synthesis of gold nanoparticles using alga Tetraselmis kochinensis. Mater Lett 79: 116–118.
  85. 85. Abboud Y, Saffaj T, Chagraoui A, Bouari AE, Brouzi K, Tanane O, Ihssane B (2014). Biosynthesis, characterization and antimicrobial activity of copper oxide nanoparticles (CONPs) produced using brown alga extract (Bifurcaria bifurcata). Appl Nanosci 4: 571–576.
  86. 86. Abdel-Raouf N, Al-Enazi NM, Ibraheem IBM (2013). Green biosynthesis of gold nanoparticles using Galaxaura elongata and characterization of their antibacterial activity. Arab J Chem doi:10.1016/j.arabjc.2013.11.044.
  87. 87. Dhas TS, Kumar VG, Karthick V, Angel KJ, Govindaraju K (2014). Facile synthesis of silver chloride nanoparticles using marine alga and its antibacterial efficacy. Spectrochim Acta A 120: 416–420.
  88. 88. Jena J, Pradhan N, Dash BP, Sukla LB, Panda PK (2013). Biosynthesis and characterization of silver nanoparticles using microalga Chlorococcum humicola and its antibacterial activity. Int J Nanomater Bios 3: 1–8.
  89. 89. Jena J, Pradhan N, Dash BP, Panda PK, Mishra BK (2015). Pigment mediated biogenic synthesis of silver nanoparticles using diatom Amphora sp. and its antimicrobial activity. J Saud Chem Soc 19 (6): 661–666.
  90. 90. Kathiraven T, Sundaramanickam A, Shanmugam N, Balasubramanian T (2015). Green synthesis of silver nanoparticles using marine algae Caulerpa racemosa and their antibacterial activity against some human pathogens. Appl Nanosci 5: 499–504.
  91. 91. Sudha SS, Rajamanickam K, Rengaramanujam J (2013). Green synthesis of silver nanoparticles using marine algae Caulerpa racemose and their antibacterial activity against some human pathogens. Indian J Exp Biol 52: 393–399.
  92. 92. Merin DD, Prakash S, Bhimba BV (2010). Antibacterial screening of silver nanoparticles synthesized by marine micro algae. Asian Pac J Trop Med 3: 797–799.
  93. 93. Mohandass C, Vijayaraj AS, Rajasabapathy R, Satheeshbabu S, Rao SV, Shiva C, De-Mello L (2013). Biosynthesis of silver nanoparticles from marine. seaweed Sargassum cinereum and their antibacterial activity. Indian J Pharm Sci 75: 606–610.
  94. 94. Sheeba JM, Thambidurai S (2009). Extraction, characterization, and application of seaweed nanoparticles on cotton fabrics. J Appl Polym Sci 113: 2287–2292.
  95. 95. Naveena BE, Prakash S (2013). Biological synthesis of gold nanoparticles using marine algae Gracilaria corticata and its application as a potent antimicrobial and antioxidant agent. Asian J Pharm Clin Res 6: 179–182.
  96. 96. Rajesh S, Raja DP, Rathi JM, Sahayaraj K (2012). Biosynthesis of silver nanoparticles using Ulva fasciata (Delile) ethyl acetate extract and its activity against Xanthomonas campestris pv. Malvacearum. J Biopest 5: 119–128.
  97. 97. Rajeshkumar S, Malarkodi C, Vanaja M, Gnanajobitha G, Paulkumar K, Kannan C, Annadurai G (2013). Antibacterial activity of algae mediated synthesis of gold nanoparticles from Turbinaria conoides. Der Pharma Chem 5: 224–229
  98. 98. Ramakritinan CM, Kaarunya E, Shankar S, Kumaraguru AK (2013). Antibacterial effects of Ag, Au and bimetallic (Ag–Au) nanoparticles synthesized from red algae. Solid State Phenom 201: 211–230.
  99. 99. Sahayaraj K, Rajesh S, Rathi JM (2012). Silver nanoparticles biosynthesis using marine alga Padina pavonica (Linn.) and its microbicidal activity. Dig J Nanomater Biostruct 7: 1557–1567.
  100. 100. Shukla MK, Singh RP, Reddy CRK, Jha B (2012). Synthesis and characterization of agar-based silver nanoparticles and nanocomposite film with antibacterial applications. Bioresour Technol 107: 295–300.
  101. 101. Suganya KU, Govindaraju K, Kumar VG, Dhas TS, Karthick V, Singaravelu G, Elanchezhiyan M (2015). Blue green alga mediated synthesis of gold nanoparticles and its antibacterial efficacy against Gram positive organisms. Mater Sci Eng C 47: 351–356.
  102. 102. Marimuthu V, Palanisamy SK, Sesurajan S, Sellappa S (2011). Biogenic silver nanoparticles by Gelidiella acerosa extract and their antifungal effects. Avicenna J Med Biotechnol 3: 143–148.
  103. 103. Rajeshkumar S, Malarkodi C, Paulkumar K, Vanaja M, Gnanajobitha G, Annadurai G (2014). Algae mediated green fabrication of silver nanoparticles and examination of its antifungal activity against clinical pathogens. Int J Met ID: 692643, 2014: 8. doi:10.1155/2014/692643.
  104. 104. Boca SC, Potara M, Gabudean A-M, Juhem A, Baldeck PL, Astilean S (2011). Chitosan-coated triangular silver nanoparticles as a novel class of biocompatible, highly effective photothermal transducers for in vitro cancer cell therapy. Cancer Lett 311: 131–140.
  105. 105. Govindaraju K, Krishnamoorthy K, Alsagaby SA, Singaravelu G, Premanathan M (2015). Green synthesis of silver nanoparticles for selective toxicity towards cancer cells. IET Nanobiotechnol 9 (6): 325–30.
  106. 106. Eroglu E, Chen X, Bradshaw M, Agarwal V, Zou J, Stewart SG, Duan X, Lamb RN, Smith SM, Raston CL, Iyer KS (2013). Biogenic production of palladium nanocrystals using microalgae and their immobilization on chitosan nanofibers for catalytic applications. RSC Adv 3: 1009–1012.
  107. 107. Sharma B, Purkayastha DD, Hazra S, Thajamanbi M, Bhattacharjee CR, Narendra Nath Ghosh NN, Rout J (2014). Biosynthesis of fluorescent gold nanoparticles using an edible freshwater red alga, Lemanea fluviatilis (L.) C.Ag. and antioxidant activity of biomatrix loaded nanoparticles. Bioprocess Biosyst Eng 37: 2559–2565.
  108. 108. LewisOscar F, MubarakAli D, Nithya C, Priyanka R, Gopinath V, Alharbi N S, Thajuddin N (2015). One pot synthesis and anti-biofilm potential of copper nanoparticles (CuNPs) against clinical strains of Pseudomonas aeruginosa. Biofouling 3 (4): 379–391.
  109. 109. Zonaro E, Lampis S, Turner RJ, Qazi SJS, Vallini G (2015). Biogenic selenium and tellurium nanoparticles synthesized by environmental microbial isolates efficaciously inhibit bacterial planktonic cultures and biofilms. Front Microbiol 6: 584.
  110. 110. Ashajyothi C, Manjunath, Kelmani CR (2015). Prevention of multiple drug resistant bacterial biofilm by synergistic action of biogenic silver nanoparticle and antimicrobials. J Microbiol Biotechnol Res 5 (1): 14–21.
  111. 111. Raja K, Namashivayam S, Christo BB, Karthigai Arasu SM, Arum Muthukumar K, Deepak K (2013). Anti biofilm effect of biogenic silver nanoparticles coated medical devices against biofilm of clinical isolate of S. aureus. GJMR 13 (3): 25–30.
  112. 112. Apte M, Sambre D, Gaikawad S, Joshi S, Bankar A, Kumar AR, Zinjarde S (2013). Psychrotrophic yeast Yarrowia lipolytica NCYC 789 mediates the synthesis of antimicrobial silver nanoparticles via cell-associated melanin. AMB Express 3 (1): 32.
  113. 113. Kalishwaralal K, Barath Mani Kanth S, Pandian SR, Deepak V, Gurunathan S (2010). Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B Biointerfaces 79 (2): 340–344.
  114. 114. Hernandez-Delgadillo R, Velasco-Arias D, Diaz D, Arevalo-Nino K, Garza-Enriquez M, De la Garza-Ramos MA, Cabral-Romero C (2012). Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm. Int J Nanomed 7: 2109–2113.
  115. 115. Hernandez-Delgadillo R, Velasco-Arias D, Martinez-Sanmiguel JJ, Diaz D, Zumeta-Dube I, Arevalo-Nino K, Cabral-Romero C (2013). Bismuth oxide aqueous colloidal nanoparticles inhibit Candida albicans growth and biofilm formation. Int J Nanomed 8: 1645–1652.
  116. 116. Anghel I, Grumezescu AM (2013). Hybrid nanostructured coating for increased resistance of prosthetic devices to staphylococcal colonization. Nanoscale Res Lett 8 (1): 6.
  117. 117. Hwang YY, Ramalingam K, Bienek DR, Lee V, You T, Alvarez R (2013). Antimicrobial activity of nanoemulsion in combination with cetylpyridinium chloride on multi-drug resistant Acinetobacter baumannii. Antimicrob Agents Chemother 57 (8): 3568–75.
  118. 118. Sawant SN, Selvaraj V, Prabhawathi V, Doble M (2013). Antibiofilm roperties of silver and gold incorporated PU, PCLm, PC and PMMA nanocomposites under two shear conditions. PLoS One 8 (5): e63311.
  119. 119. Monteiro DR, Silva S, Negri M, Gorup LF, de Camargo ER, Oliveira R, Barbosa DB, Henriques M (2013). Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. Mycose 56 (6): 672–80.
  120. 120. Zhang K, Cheng L, Imazato S, Antonucci JM, Lin NJ, Lin-Gibson S, Bai Y, Xu HH (2013). Effects of dual antibacterial agents MDPB and nano-silver in primer on microcosm biofilm, cytotoxicity and dentine bond properties. J Dent 41 (5): 464–474.
  121. 121. Zhang K, Li F, Imazato S, Cheng L, Liu H, Arola DD, Bai Y, Xu HH (2013). Dual antibacterial agents of nano-silver and 12-methacryloyloxydodecylpyridinium bromide in dental adhesive to inhibit caries. J Biomed Mater Res B Appl Biomater 101 (6): 929–938.
  122. 122. Wu C, Labrie J, Tremblay YD, Haine D, Mourez M, Jacques M (2013). Zinc as an agent for the prevention of biofilm formation by pathogenic bacteria. J Appl Microbiol 115 (1): 30–40.
  123. 123. Grumezescu AM, Chifiriuc MC, Saviuc C, Grumezescu V, Hristu R, Mihaiescu DE, Stanciu GA, Andronescu E (2012). Hybrid nanomaterial for stabilizing the antibiofilm activity of Eugenia carryophyllata essential oil. IEEE Trans Nanobiosci 11 (4): 360–365.
  124. 124. Grumezescu AM, Saviuc C, Chifiriuc MC, Hristu R, Mihaiescu DE, Balaure P, Stanciu G, Lazar V (2011). Inhibitory activity of Fe(3) O(4)/oleic acid/usnic acid-core/shell/extra-shell nanofluid on S. aureus biofilm development. IEEE Trans Nanobiosci 10 (4): 269–274.
  125. 125. Eshed M, Lellouche J, Matalon S, Gedanken A, Banin E (2012). Sonochemical coatings of ZnO and CuO nanoparticles inhibit Streptococcus mutans biofilm formation on teeth model. Langmuir 28 (33): 12288–12295.
  126. 126. Cheow WS, Hadinoto K (2012). Green preparation of antibiotic nanoparticle complex as potential anti-biofilm therapeutics via self-assembly amphiphile-polyelectrolyte complexation with dextran sulfate. Colloids Surf B Biointerfaces 92: 55–63.
  127. 127. Sun LM, Zhang CL, Li P (2012). Characterization, antibiofilm, and mechanism of action of novel PEG-stabilized lipid nanoparticles loaded with terpinen-4-ol. J Agric Food Chem 60 (24): 6150–6156.
  128. 128. Lellouche J, Friedman A, Lahmi R, Gedanken A, Banin E (2012). Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles. Int J Nanomed 7: 1175–1188.
  129. 129. Lellouche J, Friedman A, Lellouche JP, Gedanken A, Banin E (2012). Improved antibacterial and antibiofilm activity of magnesium fluoride nanoparticles obtained by water-based ultrasound chemistry. Nanomedicine 8 (5): 702–711.
  130. 130. Lellouche J, Kahana E, Elias S, Gedanken A, Banin E (2009). Antibiofilm activity of nanosized magnesium fluoride. Biomaterials 30 (30): 5969–5978.
  131. 131. Lellouche J, Friedman A, Gedanken A, Banin E (2012). Antibacterial and antibiofilm properties of yttrium fluoride nanoparticles. Int J Nanomed 7: 5611–5624.
  132. 132. Chifiriuc C, Grumezescu V, Grumezescu AM, Saviuc C, Lazar V, Andronescu E (2012). Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity. Nanoscale Res Lett 7: 209.
  133. 133. Khan S, Alam F, Azam A, Khan AU (2012). Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm. Int J Nanomed 7: 3245–3257.
  134. 134. Mohanty S, Mishra S, Jena P, Jacob B, Sarkar B, Sonawane A (2012). An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomedicine 8 (6): 916–924.
  135. 135. Kishen A, Shi Z, Shrestha A, Neoh KG (2008). An investigation on the antibacterial and antibiofilm efficacy of cationic nanoparticulates for root canal disinfection. J Endod 34 (12): 1515–1520.
  136. 136. Styan K, Abrahamian M, Hume E, Poole-Warren LA (2007). Antibacterial polyurethane organosilicate nanocomposites. Key Eng Mater 342: 757–760.
  137. 137. Ali DM, Divya C, Gunasekaran M, Thajuddin N (2011). Biosynthesis and characterization of silicon-germanium oxide nanocomposite by diatom. Dig J Nanomater Biostruct 6 (1): 117–120.
  138. 138. Gomathi (2009). Studies on Thraustochytrids sp., for PUFA production and nanoparticles synthesis. M.Phil thesis, CAS in Marine Biology, Annamalai University, 60 pp.
  139. 139. Kathiresan K (2007). Proceedings of the 5th National Conference of Indian Association of Applied Microbiologists on Emerging Trends & Evolving Technologies in Applied Microbiology with Special Reference to Microbial Nanotechnology, Kanchipuram, India, January 11–12, 2007, 35.
  140. 140. Kuppusamy P, Mashitah MY, Maniam GP, Govindan N (2014). Biosynthesized gold nanoparticle developed as a tool for detection of HCG hormone in pregnant women urine sample. Asian Pacific J Trop Dis 4 (30): 237.
  141. 141. Brondani D, Scheeren CW, Dupont J, Vieira IC (2009). Biosensor based on platinum nanoparticles dispersed in ionic liquid and laccase for determination of adrenaline. Sens Actuat B Chem 140 (1): 252–259.
  142. 142. Zhang Y, Gao G, Qian Q, Cui D (2012). Chloroplasts-mediated biosynthesis of nanoscale Au–Ag alloy for 2-butanone assay based on electrochemical sensor. Nanoscale Res Lett 7 (1): 475.

Written By

Felix LewisOscar, Sasikumar Vismaya, Manivel Arunkumar, Nooruddin Thajuddin, Dharumadurai Dhanasekaran and Chari Nithya

Submitted: 10 February 2016 Reviewed: 07 March 2016 Published: 29 June 2016